SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ZIM Laboratories gets CDSCO’s approval for Naproxen plus Esomeprazole Capsules

03 Dec 2025 Evaluate

ZIM Laboratories has received permission from the Indian Central Drugs Standard Control Organization (CDSCO) for its novel Fixed Dose Combination formulation: Naproxen Delayed Release and Esomeprazole Capsules (375 mg/500 mg + 20 mg/20 mg). This product has been developed using ZIM’s proprietary drug delivery systems, comprising Naproxen Delayed-Release Minitablets, and Esomeprazole Pellets, filled together in a single hard gelatin capsule offering a differentiated and patient-friendly delivery platform and is part of its New Innovative Product (NIP) pipeline. 

This approval strengthens ZIM’s presence in the pain management and gastro-protective therapeutic areas. ZIM has already signed a commercial supply agreement with an Indian pharmaceutical company for this product and is working toward commercial launch in India in FY 2026-27 (FY27). The approval also reinforces ZIM’s strategy of developing innovative, differentiated generics leveraging advanced formulation technologies.

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.


Zim Laboratories Share Price

72.17 -0.90 (-1.23%)
13-Apr-2026 14:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1659.30
Dr. Reddys Lab 1230.25
Cipla 1211.55
Zydus Lifesciences 923.60
Lupin 2324.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×